Stem cells in myelotoxicity

Toxicology

Volumn 267, Issue 1-3, 2010, Pages 112-117

  Parent Massin, D ^a   Hymery, N ^a   Sibiril, Y ^a  

^a Universite Europeenne de Bretagne   (France)

Author keywords

Hematopoietic progenitors; Hematopoietic stem cells; Hematotoxicity; Myelotoxicity; Stem cells; Toxicity study

Indexed keywords

GROWTH FACTOR; XENOBIOTIC AGENT;

ARTICLE; BLOOD CELL; BONE MARROW DEPRESSION; BONE MARROW TOXICITY; BURST FORMING UNIT E; CELL DIFFERENTIATION; CELL INTERACTION; CELL TYPE; CLONOGENIC ASSAY; COLONY FORMING UNIT; COLONY FORMING UNIT GM; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STEM CELL; STROMA CELL;

ANEMIA, APLASTIC; BONE MARROW; CELL DIFFERENTIATION; CELL PROLIFERATION; HEMATOPOIESIS; HUMANS; STEM CELLS; TOXICITY TESTS; XENOBIOTICS;

MAMMALIA; MURINAE;

EID: 71849111471     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2009.10.031     Document Type: Article

References (71)

1. Ascencao J.L., Flynn P.J., Wachamm A., et al. Quinidine induced neutropenia: a drug-dependant inhibition of granulocyte colony generation. Acta Haematol. 72 (1984) 349-354
2. Bradley T.R., and Metcalf D. The growth of mouse bone marrow cells in vitro. Aust. J. Exp. Biol. Med. 44 (1966) 287-300
3. Barrett A.J., Weller E., Rozengurt, Longhurst P., and Humble J.G. Amidopyrine agranulocytosis: drug inhibition of granulocytes colonies in the presence of patient serum. Br. Med. J. 2 (1976) 850-851
4. Boogaerts M.A., Peters M., Peersman C., Kesteloot H., and Verwilghen L. Mechanism of apridine induced agranulocytosis: direct toxicity on CFU-GM and CFU-GEMM. Scand. J Haematol. 32 (1984) 175-178
5. - cells for the in vitro CFU-MK assay. ATLA 27 (1999) 120
6. Clarke E., Pereira C., Chaney R., Woodside S., Eaves A.C., and Damen J. Toxicity testing using hematopoietic stem cell assays. Regen. Med. 2 (2007) 947-956
7. Dainiak N., Worthington M., Riordan M.A., Kreczko S., and Goldman L. 3′-Azido-3′-deoxythimidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells. Br. J. Haematol. 69 (1988) 299-304
8. Dal Negro G., Vandin L., Bonato M., and Sciuscio D. Toward refinement of the colony-forming unit-granulocyte/macrophage clonogenic assay: inclusion of a metabolic system. Toxicol. In Vitro 20 (2006) 743-749
9. Davila J.C., Cezar G.G., Thiede M., Strom S., Miki T., and Trosko J. Use and application of stem cells in toxicology. Toxicol. Sci. 79 (2004) 214-223
10. Deldar A., and Stevens C.E. Development and application of in vitro models of hematopoiesis to drug development. Toxicol. Pathol. 21 (1993) 231-240
11. Dexter T.M., Allen T.D., and Lajtha L.G. Condition controlling the proliferation of hematopoietic cells in vitro. J. Cell Physiol. 91 (1977) 335-344
12. Diodovich C., Malerba I., Bowe G., et al. Naphthalene exposure: effects on gene expression and proliferation in human cord blood cells. J. Biochem. Mol. Toxicol. 17 (2003) 286-294
13. Diodovich C., Bianchi M.G., Bowe G., et al. Response of human cord blood cells to styrene exposure: evaluation of its effects on apoptosis and gene expression by genomic technology. Toxicology (2004) 145-157
14. Diodovich C., Malerba I., Ferrario D., et al. Gene and protein expressions in human cord blood cells after exposure to acrylonitrile. J. Biochem. Mol. Toxicol. 19 4 (2005) 204-212
15. Diodovich C., Ferrario D., Casati B., et al. Sensitivity of human cord blood cells to tetrachloroethylene: cellular and molecular endpoints. Arch. Toxicol. 79 (2005) 508-514
16. Ferlini C., Distefano M., Pierelli L., et al. A new method to evaluate in vitro myelotoxicity of antitumour agents in the first steps of drug development. Pharmacol. Toxicol. 89 (2001) 231-236
17. Freund Y.R., Dabbs J., Creek M.R., Phillips S.J., Tyson C.A., and MacGregor J.T. Synergistic bone marrow toxicity of pyrimethamine and zidovudine in murine in vivo and in vitro models: mechanism of toxicity. Toxicol. Appl. Pharmacol. 181 (2002) 16-26
18. Friedenstein A.J., Chailakhyan R.K., and Laliykina K.S. The development of fibroblasts colonies in monolayer cultures of guinea pig bone marrow and spleen. Cell Tissue Kinet. 3 (1970) 393-403
19. Froquet R., Sibiril Y., and Parent-Massin D. Improvement of megakaryocyte progenitor culture for toxicological investigations. Toxicol. In Vitro 15 (2001) 691-699
20. Gómez S.G., Bueren J.A., Faircloth G., and Albella B. Use of CFU-GM assay for prediction of human maximum tolerated dose of a new antitumoral drug: Yondelis (ET-743). Toxicol. In Vitro 17 (2003) 671-674
21. Gribaldo L., Bueren J., Deldar A., Hockland P., Meredith C., Moneta D., Mossesso P., Parchment R., Parent-Massin D., Pessina A., San Roman J., and Schoeters G. Evaluation of haematotoxic effects using in vitro systems. The report and recommendations of ECVAM Workshop 17. ATLA 24 (1996) 211-231
22. Gribaldo L., Casati S., Figliuzzi L., and Marafante E. In vitro myelotoxicity of environmental contaminants. Environ. Toxicol. Pharmacol. 6 (1998) 135-141
23. Gribaldo L., Malerba I., Collota A., Casati S., and Pessina A. Inhibition of CFU-E/BFU-E by 3′-azido-3′-deoxythymidine, chlorpropamide, and protoporphirin IX zinc (II): a comparison between direct exposure of progenitor cells and long-term exposure of bone marrow cultures. Toxicol. Sci. 58 (2000) 96-101
24. Irvine A.E., Morris T.C.M., Kelly C.J., and Mc Cracken N. Tirarcillin-induced neutropenia corraoborated by in vitro CFU-C toxicity. Acta Haematol. 70 (1983) 364-368
25. Kelton J.G., Huang A.T., Mold N., Logue G., and Rosse W.F. The use of in vitro techniques to study drug-induced pancytopenia. N. Engl. J. Med. 301 (1979) 621-624
26. Lautraite S., Parent-Massin D., Rio B., and Hoellinger H. Comparison of toxicity induced by T-2 toxin on human and rat granulo-monocytic progenitors with an in vitro model. Hum. Exp. Toxicol. 14 (1995) 672-678
27. + hematopoietic progenitor. Toxicol. In Vitro 19 (2005) 1015-1024
28. + bone marrow progenitors causes decreased steady state mitochondrial DNA (mtDNA) and increased lactate production. Hum. Exp. Toxicol. 23 (2004) 173-185
29. Lind D.E., Levi J.A., and Vincent P.C. Amodiaquine-induced agranulocytosis: toxic effect of Amodiaquine in bone marrox cultures in vitro. Br. Med. J. 1 (1973) 458-460
30. Lutton J.D., Ibraham N.G., Friedland M., and Levere R.D. The toxic effects of heavy metal on rat bone marrow in vitro erythropoiesis: protective role of hemin and zinc. Environ. Res. 35 (1984) 97-103
31. Lutton J.D., Mathew A., Levere R.D., and Abraham N.G. Role of heme metabolism in AZT-induced bone marrow toxicity. Am. J. Hematol. 35 (1990) 1-5
32. Malerba I., Castoldi A.F., Parent-Massin D., and Gribaldo L. In vitro myelotoxicity of propanil and 3,4-dichloroaniline on murine and human CFU-E/BFU-E progenitors. Toxicol. Sci. 69 (2002) 433-438
33. Malerba I., Casati S., Diodovich C., Parent-Massin D., and Gribaldo L. Inhibition of CFU-E/BFU-E and CFU-GM colony growth by Cyclophosphamide, 5-Fluorouracil and Taxol: development of a high-throughput in vitro method. Toxicol. In Vitro. 18 (2004) 293-300
34. Masubuchi N., May R.D., and Atsumi R. A predictive model of human myelotoxicity using five camptothecin derivatives and the in vitro colony-forming unit granulocyte/macrophage assay. Clin. Cancer Res. 10 (2004) 6722-6731
35. Masubuchi N. Risk assessment of human myelotoxicity of anticancer drugs: a predictive model and the in vitro colony forming unit granulocyte/macrophage (CFU-GM) assay. Pharmazie 61 (2006) 135-139
36. Molyneux G., Gibson F.M., Chen C.M., et al. The haematotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse. Int. J. Exp. Pathol. 89 (2008) 138-158
37. Naughton B.A., and Naughton G.K. Hematopoiesis on nylon mesh templates. Ann. N.Y. Acad. Sci. 554 (1989) 125-140
38. Naughton B.A., Sibanda D., Azar L., and San Roman J. Differential effects of drugs upon hematopoiesis can be assessed in long-term bone marrow culture established on nylon screens. Proc. Soc. Exp. Biol. Med. 199 (1992) 481-490
39. Parchment R.E., Volpe D.A., LoRusso P.M., Erickson-Miller C.L., Murphy M.J., and Grieshaber C.K. In vivo-in vitro correlation of myelotoxicity of 9-methoxypyrazoloacridine (NSC-366140, PD115934) to myeloid and erythroid hematopoietic progenitors from human, murine, and canine marrow. J. Natl. Cancer Inst. 86 (1994) 273-280
40. Parchment R.E., Gordon M., Grieshaber C.K., Sessa C., Volpe D., and Ghielmini M. Predicting hematological toxicity (myelosuppression) of cytotoxic drug therapy from in vitro tests. Ann. Oncol. 9 (1998) 357-364
41. Parent-Massin D., and Thouvenot D. In vitro study of pesticide hematotoxicity in human and rat progenitors. J. Pharmacol. Toxicol. Methods 30 (1993) 203-207
42. Parent-Massin D., Fuselier R., and Thouvenot D. In vitro toxicity of trichothecenes on human haematopoietic progenitors. Food. Addit. Contam. 11 (1994) 441-447
43. Parent-Massin D., Fournier V., Amade P., et al. Evaluation of the toxicological risk to humans of caulerpenyne using human hematopoietic progenitors, melanocytes, and keratinocytes in culture. J. Toxicol. Environ. Health 47 (1996) 47-59
44. Parent-Massin D., and Parchment R.E. Haematotoxicity of mycotoxins. Rev. Med. Vet. 149 (1998) 591-598
45. Parent-Massin D. Relevance of clonogenic assays in food haematotoxicology. In: Balls M., Zeller A.M., and Halder M. (Eds). Progress in the Reduction, Refinement and Replacement of Animal Experimentation. Development in Animal and Veterinary Sciences vol. 31 (2000), Elsevier Science 709-714
46. Parent-Massin, D., Pessina, A., Van Den Heuvel, R., Albella, B., 2002. Development and prevalidation of in vitro assays for the prediction of thrombocytopenia. Final report to ECVAM, Contract 15402-1999-11 FIED ISP FR, 88 pp.
47. Parent-Massin D., and Sibiril Y. CFU-MK assay for thrombocytopenia. Curr. Protoc. Toxicol. 37 (2008) 20.5.1-20.5.14
48. Parent-Massin D., Le Borgne G., Becourt-Lhote N., Jehannin B., Sibiril Y., and Claude N. Improvement of monkey (Macaca fascilaris) hematopoietic clonogenic assays for toxicological studies. Toxicol. Sci. (2008) (Abstract)
49. Pessina A., Albella B., Bueren J., et al. Method development for a prevalidation study of the in vitro GM-CFU assay for predicting myelotoxicity. In: Balls M., Van Zeller M., and Halder M.E. (Eds). Progress in the Reduction, Refinement and Replacement of animal Experimentation (2000), Elsevier Science, Amsterdam 679-692
50. Pessina A., Albella B., Bayo M., et al. Application of the CFU-GM assay to predict acute drug-induced Neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics. Toxicol. Sci. 75 (2003) 355-367
51. Pessina A., and Bonomi A. CFU-GM assay for evaluation of drug myelotoxic activity. Curr. Protoc. Toxicol. 37 (2007) 20.2.1-20.2.18
52. Pessina A., Parent-Massin D., Albella B., Van Den Heuvel R., Casati S., Croera C., Malerba I., Sibiril Y., Gomez S., de Smedt A., and Gribaldo L. Application of human CFU-MK assay to predict potential thrombocytotoxicity of drugs. Toxicol. In Vitro (2009) 194-200
53. Pluznik D.H., and Sachs L. The induction of clones of normal mast cells by a substance from conditioned medium. Exp. Cell Res. 43 (1966) 553-563
54. Rich I.N., and Hall K.M. Validation and development of a predictive paradigm for hematoxicology using a multifunctional bioluminescence colony-forming proliferation assay. Toxicol. Sci. 87 (2005) 427-441
55. Rio B., Lautraite S., and Parent-Massin D. In vitro toxicity of trichothecenes on human erythroblastic progenitors. Hum. Exp. Toxicol. 16 (1997) 673-679
56. Rio B., and Parent-Massin D. Improvement of erythroblastic progenitor culture for toxicological investigations. Toxicol. Methods 7 (1997) 363-380
57. Rio B., Parent-Massin D., Lautraite S., and Hoellinger H. Effects of diphenyl-ether herbicide oxyfluorfen on human BFU-E/CFU-E development and hemoglobin synthesis. Hum. Exp. Toxicol. 16 (1997) 11-22
58. Sibiril Y., Parent-Massin D., Albella L., et al. Development and prevalidation of an in vitro assays for the prediction of thrombocytopenia. Eurotox 2002. Budapest (Hongrie). Toxicol. Lett. 135 (2002) 137 (Abstract)
59. Smith A. A glossary for stem-cell biology. Nature 441 (2006) 1060
60. Song H., Vita M., Sallam H., et al. Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro. Cancer Chemother. Pharmacol. 60 (2007) 841-849
61. Stephenson J.R., Axelrad A.A., Mc Leod D.L., and Shreeve M.M. Induction of colonies of hemoglobin-synthesizing cells by erythropoietin. Proc. Natl. Acad. Sci. USA 68 (1971) 1542-1546
62. Tepperman A.D., Curtis J.E., and Mc Culloch E.A. Erythropoietic colonies in cultures of human marrow. Blood 44 (1974) 659-669
63. Van den Heuvel R., Leppens H., Bertels N., and Schoeters G. Comparison of haematotoxicity induced by lead and the benzene metabolites catechol and hydroquinone on human and murine haematopoietic progenitor cells using in vitro assays. Cell. Biol. Toxicol. 15 (1999) 101-110
64. Van den Heuvel R., Leppens H., Nuyten J.M., and Schoeters G. Haematopoietic lineage sensitivity and individual susceptibility to PCB126: relation to glutathione-S-transferase. Toxicol. In Vitro 13 (1999) 605-609
65. Van Den Heuvel R.L., Leppens H., and Schoeters G.E.R. Use in vitro assays to assess hematotoxic effects of environmental compounds. Cell Biol. Toxicol. 17 (2001) 107-116
66. Viale M., Minetti S., Ottone M., Lerza R., Parodi B., and Pannacciulli I. Preclinical in vitro evaluation of hematotoxicity of the cisplatin-procaine complex DPR. Anticancer Drugs 14 (2003) 163-166
67. Volpe D.A., and Warren M.K. Myeloid clonogenic assays for comparison of the in vitro toxicity of alkylating agents. Toxicol. In Vitro 17 (2003) 271-277
68. Weisel K.C., Yildirim S., Schweikle E., Kanz L., and Möhle R. Effect of FLT3 inhibition on normal hematopoietic progenitor cells. Ann. N.Y. Acad. Sci. 1106 (2007) 190-196
69. Yamaguchi F., Furuhama K., Miyamoto M., Sagara-Ishijama N., and Takayama S. Application of hematopoietic progenitors assays for the estimation of hematotoxicity in rats. J. Pharmacol. Toxicol. Methods 31 (1994) 71-77
70. Young G.A.R., and Vincent P. Drug-induced agranulocytosis. Clin. Haematol. 9 (1980) 483-504
71. 2 in aplastic anemia. Clin. Toxicol. 17 (1980) 359-373